SEC Form 4 · accession 0001209191-18-005579
CONCERT PHARMACEUTICALS, INC. · CNCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nancy Stuart
Officer — Chief Operating Officer
Period of report
Jan 25, 2018
Accepted (ET)
Jan 26, 2018 · 4:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 25, 2018 | M | 48,882 | $4.58 | A | 151,860 | D | |
| Common Stock | Jan 25, 2018 | F | 11,066 | $20.23 | D | 140,794 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $4.58 | Jan 25, 2018 | M | 48,882 | D | — | Dec 19, 2018 | Common Stock | 48,882 | 0 | D |
Explanation of responses
- F1This option is fully vested.